NetTargets is advancing an AI-powered platform to discover novel combination drug strategies — accelerating next-generation therapeutics under the Global AI Voucher program.
NetTargets Inc.
01 May 2025
NetTargets is advancing an AI-powered platform to discover novel combination drug strategies — accelerating next-generation therapeutics under the Global AI Voucher program.
NetTargets will contribute its proprietary AI-based systems biology modeling technology to WOOJUNGBIO’s Open Innovation Project. By enabling quantitative simulation of biological responses and prediction of drug mechanisms, we are helping to shape a next-generation bioevaluation platform in the era of AI transformation.
NetTargets has been selected as one of the top 10 semifinalists among hundreds of drug discovery startups worldwide. The AI Discovery Award is an annual recognition by Nebius AI, a European AI-centric public cloud provider with global reach.
